Top Stories
-
A new study has identified a novel combination therapy, using napabucasin with radiation therapy, in treating aggressive pediatric brain tumors.
Topic
-
The V Foundation Translational grant supports Dr. Wechsler-Reya's innovative research in identifying new targets and potential therapies for pediatric brain tumors.
Topic
-
Source:
Focused Ultrasound FoundationResearchers at Columbia have begun a clinical trial to assess the feasibility of using focused ultrasound to facilitate the delivery of chemotherapy to progressive diffuse intrinsic pontine gliomas.
-
Source:
Department of PediatricsA team of Columbia physician-scientists have opened a trial of a noninvasive, focused ultrasound approach to open the blood-brain barrier to better treat pediatric brain tumors.
Topic
Latest News
- February 17, 2023
Dr. Gill is focused on improving therapies for patients with brain cancer and shares why building thoughtful mentor-mentee relationships are critical in science and medicine.
Topic
- January 9, 2023
Translational scientist Robert Wechsler-Reya, PhD, an expert in pediatric brain cancer, has joined the Herbert Irving Comprehensive Cancer Center as scientific director of Brain Tumor Research.
Topic
-
Source:
CUIMC NewsroomNovember 10, 2022Dr. Jeffrey Bruce: "This new approach has the potential to transform treatment for patients with brain cancer, where the outlook for survival remains very poor."
Topic
-
Source:
CUIMC NewsroomJuly 18, 2022Dr. Ben Izar and collaborators have completed one of the most comprehensive studies of the cells inside melanoma brain metastases, uncovering details that could spur development of novel therapies.
Topic
- February 4, 2022
A clinical trial led by Columbia neuro-oncology team suggests that a new type of anti-cancer drug has promise for patients with glioblastoma.
Topic
